PLRZ (Polyrizon) Common Stock: $0.00 Mil (As of Dec. 2025)


PLRZ Polyrizon Ltd PLRZ
14 GF Score
Price $12.61
! 4 Warning Signs
View Full Analysis

What is Polyrizon Common Stock?

Polyrizon PLRZ +1.28% 14 Common Stock is $0.00 Mil as of Dec. 2025. GuruFocus rates PLRZ with a GF Score™ of 14/100. The stock has 4 warning signs investors should review.

Polyrizon Common Stock Historical Data

* Premium members only.

The historical data trend for Polyrizon's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polyrizon Common Stock Chart

Polyrizon Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Common Stock
0.00 0.00 0.00 0.00

Polyrizon Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
PLRZ
14GF Score
Polyrizon Ltd PLRZ
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Polyrizon Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.00 Mil mean?
Polyrizon (PLRZ) has a Common Stock of $0.00 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Polyrizon and its competitors.
Is Polyrizon's Common Stock too high?
Polyrizon's current Common Stock is $0.00 Mil. Overall, Polyrizon has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Polyrizon's Common Stock compare to SKYE and NEUP?
Polyrizon's Common Stock of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Polyrizon and its competitors. Polyrizon's current Common Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polyrizon stock overvalued right now?
Polyrizon (PLRZ) has a current Common Stock of $0.00 Mil. The current Common Stock is $0.00 Mil. Polyrizon's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Polyrizon (PLRZ), the current Common Stock is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Polyrizon Business Description

Address 5 Ha-Tidhar Street, Raanana, ISR, 4366507
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
14GF Score

Get the complete analysis for PLRZ

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.61
Price